-
1
-
-
77952151766
-
High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial H. pylori eradication
-
Sun, Q. et al. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial H. pylori eradication. Helicobacter 15, 233-238 (2010).
-
(2010)
Helicobacter
, vol.15
, pp. 233-238
-
-
Sun, Q.1
-
2
-
-
48249142046
-
A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for H. pylori eradication
-
Mu, F., Hu, F., Yang, G. & Cheng, H. A clinical study of proton pump inhibitor-containing quadruple regimen as first-line therapy for H. pylori eradication. Chin. J. Gastroenterol. 12, 531-534 (2007).
-
(2007)
Chin. J. Gastroenterol.
, vol.12
, pp. 531-534
-
-
Mu, F.1
Hu, F.2
Yang, G.3
Cheng, H.4
-
3
-
-
33846152938
-
Comparison of efficacy of 7-day rabeprazole-based triple therapy versus quadruple therapy for treatment of Helicobacter pylori infection
-
Zheng, Q., Pan, Y., Zhang, L. & Xiao, S. Comparison of efficacy of 7-day rabeprazolebased triple therapy versus quadruple therapy for treatment of H. pylori infection. Chin. J. Gastroenterol. 11, 645-647 (2006). (Pubitemid 46075697)
-
(2006)
Chinese Journal of Gastroenterology
, vol.11
, Issue.11
, pp. 645-647
-
-
Zheng, Q.1
Pan, Y.2
Zhang, L.3
Xiao, S.4
-
4
-
-
0034954931
-
What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis
-
Calvet, X., Gené, E., López, T. & Gisbert, J. P. What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori? A cost-effectiveness analysis. Aliment. Pharmacol. Ther. 15, 1067-1076 (2001).
-
(2001)
Aliment. Pharmacol. Ther.
, vol.15
, pp. 1067-1076
-
-
Calvet, X.1
Gené, E.2
López, T.3
Gisbert, J.P.4
-
5
-
-
35848963397
-
Meta-analysis: Duration of firstline proton-pump inhibitor based triple therapy for H. pylori eradication
-
Fuccio, L. et al. Meta-analysis: duration of firstline proton-pump inhibitor based triple therapy for H. pylori eradication. Ann. Intern. Med. 147, 553-562 (2007).
-
(2007)
Ann. Intern. Med.
, vol.147
, pp. 553-562
-
-
Fuccio, L.1
-
6
-
-
34147206129
-
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for H. pylori eradication: The HYPeR study
-
Zagari, R. M. et al. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for H. pylori eradication: The HYPeR study. Gut 56, 475-479 (2007).
-
(2007)
Gut
, vol.56
, pp. 475-479
-
-
Zagari, R.M.1
-
7
-
-
72949096113
-
Sequential therapy or triple therapy for H. pylori infection: Systematic review and metaanalysis of randomized controlled trials in adults and children
-
Gatta, L., Vakil, N., Leandro, G., Di Mario, F. & Vaira D. Sequential therapy or triple therapy for H. pylori infection: systematic review and metaanalysis of randomized controlled trials in adults and children. Am. J. Gastroenterol. 104, 3069-3079 (2009).
-
(2009)
Am. J. Gastroenterol.
, vol.104
, pp. 3069-3079
-
-
Gatta, L.1
Vakil, N.2
Leandro, G.3
Di Mario, F.4
Vaira, D.5
-
8
-
-
72949121483
-
Sequential therapy for eradication of H. pylori: A new guiding light or a false dawn?
-
Moayyedi, P. & Malfertheiner, P. editorial
-
Moayyedi, P. & Malfertheiner, P. editorial: sequential therapy for eradication of H. pylori: a new guiding light or a false dawn? Am. J. Gastroenterol. 104, 3081-3083 (2009).
-
(2009)
Am. J. Gastroenterol.
, vol.104
, pp. 3081-3083
-
-
-
9
-
-
34247844165
-
Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report
-
DOI 10.1136/gut.2006.101634
-
Malfertheiner, P. et al. Current concepts in the management of H. pylori infection: the Maastricht iii Consensus Report. Gut 56, 772-781 (2007). (Pubitemid 46854190)
-
(2007)
Gut
, vol.56
, Issue.6
, pp. 772-781
-
-
Malfertheiner, P.1
Megraud, F.2
O'Morain, C.3
Bazzoli, F.4
El-Omar, E.5
Graham, D.6
Hunt, R.7
Rokkas, T.8
Vakil, N.9
Kuipers, E.J.10
-
10
-
-
0037347305
-
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of H. pylori in duodenal ulcer patients: A prospective, randomized, mulicenter, north American trial
-
Laine, L. et al. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of H. pylori in duodenal ulcer patients: a prospective, randomized, mulicenter, north American trial. Am. J. Gastroenterol. 98, 562-567 (2003).
-
(2003)
Am. J. Gastroenterol.
, vol.98
, pp. 562-567
-
-
Laine, L.1
-
11
-
-
0023867424
-
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: Clinical and in vitro studies
-
Goodwin, C. S. et al. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J. Clin. Pathol. 41, 207-210 (1988).
-
(1988)
J. Clin. Pathol.
, vol.41
, pp. 207-210
-
-
Goodwin, C.S.1
|